General

News from The American Academy of Ophthalmology

• Week in Review: Laughter Therapy for Dry Eye, AMD and Rheumatoid Arthritis, Using AI in Diabetic Eye Disease Testing September 13, 2024
  A course of laughter therapy may have positive effects on dry eyes, the risk of developing rheumatoid arthritis may be higher in people with age-related macular degeneration (AMD), and AI could be used in the future to help with diabetic eye disease testing.
• Repeated Low-Level Red Light Therapy Could Help Manage High Myopia Progression September 12, 2024
  This multicenter, randomized, parallel-group, single-blind, randomized controlled clinical trial assessed the efficacy and safety of repeated low-level red light therapy for myopia control in children and adolescents with high myopia.
• Quality of Life May Affect Visual Acuity in Patients With Noninfectious Uveitis September 11, 2024
  Tracking quality of life outcomes may aid clinicians in managing their patients with noninfectious uveitis.
• Continued Use of 0.05% Atropine Over Time May Help Stall Myopia Progression September 10, 2024
  This paper discusses the 4th phase of the randomized controlled Low-Concentration Atropine for Myopia Progression 1 trial, which examines the efficacy and safety of various low-dose atropine concentrations for preventing pediatric myopia progression.